Literature DB >> 26672433

Unprotected distal left main bifurcation drug eluting stent restenosis: first successful experience with simultaneous kissing balloon dilatation using sirolimus coated balloon.

Ranjan Shetty1, Naveen Chandra Ganiga Sanjeeva1, Sumit Agarwal1, Manish Doshi1, Prakash Sojitra1.   

Abstract

Treatment of unprotected left main (ULM) in-stent restenosis (ISR) in patients with prior drug eluting stent implantation is challenging. Treatment usually involves complex stenting procedures or bypass grafting. Drug coated balloon (DCB) is relatively new concept which is usually used in treatment of ISR. In a patient of ULM ISR, use of DCBs is a safe, economic and a technically simple option with relatively good outcomes. We report use of simultaneous kissing balloon dilatation with novel sirolimus coated balloons (SCBs) via radial artery to treat ULM ISR.

Entities:  

Keywords:  Drug coated balloon (DCB); in-stent restenosis (ISR); unprotected left main (ULM)

Year:  2015        PMID: 26672433      PMCID: PMC4666695          DOI: 10.3978/j.issn.2223-3652.2015.07.06

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  7 in total

1.  Paclitaxel induces thrombomodulin downregulation in human aortic endothelial cells.

Authors:  Huang-Joe Wang; Te-Ling Lu; Haimei Huang; Huey-Chun Huang
Journal:  Tex Heart Inst J       Date:  2011

2.  Kissing drug-eluting balloons for the treatment of unprotected distal left main bifurcation drug-eluting stent restenosis.

Authors:  Alfonso Ielasi; Angelo Anzuini
Journal:  Cardiovasc Revasc Med       Date:  2012-09-20

3.  Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter.

Authors:  Pedro A Lemos; Vasim Farooq; Celso K Takimura; Paulo S Gutierrez; Renu Virmani; Frank Kolodgie; Uwe Christians; Alexander Kharlamov; Manish Doshi; Prakash Sojitra; Heleen M M van Beusekom; Patrick W Serruys
Journal:  EuroIntervention       Date:  2013-05-20       Impact factor: 6.534

4.  Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries.

Authors:  Tom J Parry; Ruth Brosius; Rathna Thyagarajan; Demetrius Carter; Dennis Argentieri; Robert Falotico; John Siekierka
Journal:  Eur J Pharmacol       Date:  2005-11-03       Impact factor: 4.432

5.  Simultaneous inflation of two drug-eluting balloons for the treatment of coronary bifurcation restenosis: a concept series.

Authors:  Gregory A Sgueglia; Daniel Todaro; Antonino Stipo; Edoardo Pucci
Journal:  J Invasive Cardiol       Date:  2011-11       Impact factor: 2.022

6.  Angiographic analysis of pattern of late luminal loss in sirolimus- and paclitaxel-eluting stents.

Authors:  Pierfrancesco Agostoni; John Cosgrave; Giuseppe G L Biondi-Zoccai; Giuseppe M Sangiorgi; Lei Ge; Gloria Melzi; Simon Corbett; Flavio Airoldi; Matteo Montorfano; Alaide Chieffo; Iassen Michev; Mauro Carlino; Antonio Colombo
Journal:  Am J Cardiol       Date:  2007-01-04       Impact factor: 2.778

7.  Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.

Authors:  Antonio Colombo; Jeffrey W Moses; Marie Claude Morice; Josef Ludwig; David R Holmes; Vassilis Spanos; Yves Louvard; Benny Desmedt; Carlo Di Mario; Martin B Leon
Journal:  Circulation       Date:  2004-02-23       Impact factor: 29.690

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.